The opioid crisis has garnered nationwide attention for decades and has resulted in thousands of lawsuits, subjecting pharmaceutical distributors to billions of dollars in damages. AmerisourceBergen (“Amerisource”) — one of...more
3/22/2023
/ Board of Directors ,
Class Action ,
Corporate Officers ,
Damages ,
Decisions ,
Demand Futility ,
Derivative Suit ,
Dismissals ,
Personal Liability ,
Pharmaceutical Industry ,
Red Flags Rule ,
Shareholder Litigation ,
Shareholders